Clinical Trial Detail

NCT ID NCT04136275
Title CAR-37 T Cells In Hematologic Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Marcela V. Maus, M.D.,Ph.D.
Indications

marginal zone B-cell lymphoma

peripheral T-cell lymphoma

cutaneous T cell lymphoma

CLL/SLL

chronic lymphocytic leukemia

prolymphocytic leukemia

diffuse large B-cell lymphoma

follicular lymphoma

mantle cell lymphoma

Therapies

Anti-CD37 CAR T cells

Age Groups: senior adult

No variant requirements are available.